Skip to content

Clinical trials

Terminated Phase 1/2 Lung Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Neoplasms Phase: Phase 1/2 Status: Terminated Clear all

51 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20043
20051
20062
20075
20086
20091
20102
20122
20141
20152
20163
20171
20181
20193
20202
202110
20222
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated51

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)5
M.D. Anderson Cancer Center3
NantCell, Inc.2
NextCure, Inc.2
AVAX Technologies1
Abbott1
Agennix1
Albert Einstein College of Medicine1
Cambridge University Hospitals NHS Foundation Trust1
Chroma Therapeutics1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Neoplasms51
Carcinoma, Non-Small-Cell Lung30
Neoplasm Metastasis12
Breast Neoplasms7
Ovarian Neoplasms7
Small Cell Lung Carcinoma5
Colorectal Neoplasms4
Stomach Neoplasms4
Adenocarcinoma of Lung3
Colonic Neoplasms3

Trials

Showing 1 to 25 of 51. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.